Correlation Between Nutranomics and RAMM Pharma

Can any of the company-specific risk be diversified away by investing in both Nutranomics and RAMM Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nutranomics and RAMM Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nutranomics and RAMM Pharma Corp, you can compare the effects of market volatilities on Nutranomics and RAMM Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nutranomics with a short position of RAMM Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nutranomics and RAMM Pharma.

Diversification Opportunities for Nutranomics and RAMM Pharma

0.0

Correlation Coefficient

Nutranomics  RAMM Pharma

Pay attention - limited upside

The 3 months correlation between Nutranomics and RAMM is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Nutranomics and RAMM Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RAMM Pharma Corp and Nutranomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nutranomics are associated (or correlated) with RAMM Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RAMM Pharma Corp has no effect on the direction of Nutranomics i.e., Nutranomics and RAMM Pharma go up and down completely randomly.

Pair Corralation between Nutranomics and RAMM Pharma

If you would invest  0.00  in Nutranomics on September 13, 2024 and sell it today you would earn a total of  0.00  from holding Nutranomics or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	1.59%
Values	Daily Returns

Nutranomics  vs.  RAMM Pharma Corp

Nutranomics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Nutranomics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Nutranomics showed solid returns over the last few months and may actually be approaching a breakup point.

RAMM Pharma Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days RAMM Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable primary indicators, RAMM Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Nutranomics and RAMM Pharma

The main advantage of trading using opposite Nutranomics and RAMM Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nutranomics position performs unexpectedly, RAMM Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAMM Pharma will offset losses from the drop in RAMM Pharma's long position.

The idea behind Nutranomics and RAMM Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.